Drug Metabolism Letters

Drug Metabolism Letters publishes letters, original research articles, mini-reviews, thematic issues based on mini-reviews and letters, commentaries, technical notes and drug clinical trial studies on major advances in all areas of drug metabolism and disposition.

In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; bioactivation; recent developments for the identification of drug metabolites, reactive intermediate and glutathione conjugates.

⇨ Journal Home⇨ Editorial Policies⇨ Editorial Board⇨ Board Recruitment Workflow⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments⇨ Special Offers

⇨ Author Guidelines⇨ Animated Abstracts⇨ Submit Abstracts Online⇨ Submit Manuscripts Online⇨ Open Access Funding⇨ Publishing Ethics and Rectitude⇨ Self-Archiving Policies⇨ Manuscript Transfer Facility

⇨ Thematic Issue Proposal⇨ Special Thematic Issues⇨ Guest Editor Guidelines

⇨ Reviewer Guidelines⇨ Peer Review Workflow⇨ Become a Reviewer

⇨ Contents & Abstracts⇨ Open Access Articles⇨ Free Copies Online⇨ Most Accessed Articles⇨ Purchase Articles⇨ Order Reprints⇨ Subscribe⇨ Trial Requests⇨ Library Recommendation

⇨ Journal's New Website⇨ Advertise with Us⇨ Download PDF Flyer⇨ Table of Contents Alert

Drug Metabolism Letters was launched in 2007. Dr. Zhiyang Zhao serves as the Editor-in-Chief of the journal.